Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gynecologic 2Genitourinary 1CNS 1

Conditions

Ovarian Neoplasms 513Uterine Cervical Neoplasms 366Endometrial Neoplasms 311Breast Neoplasms 131Colorectal Neoplasms 116Neoplasms 98Fallopian Tube Neoplasms 90Carcinoma, Non-Small-Cell Lung 88Stomach Neoplasms 85Pancreatic Neoplasms 81Lung Neoplasms 73Prostatic Neoplasms 69Melanoma 68Carcinoma, Ovarian Epithelial 66Neoplasm Metastasis 62Triple Negative Breast Neoplasms 52Vulvar Neoplasms 50Squamous Cell Carcinoma of Head and Neck 49Head and Neck Neoplasms 45Esophageal Neoplasms 44Peritoneal Neoplasms 41Uterine Neoplasms 40Urinary Bladder Neoplasms 40Carcinoma, Hepatocellular 35Carcinoma, Renal Cell 34Papillomavirus Infections 33Uterine Cervical Dysplasia 31Colonic Neoplasms 31Sarcoma 30Vaginal Neoplasms 28

Interventions

Radiotherapy 2TP protocol 1Paclitaxel 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Neoplasm Recurrence, Local × Gynecologic × Clear all
NCT06532539 2026-04-24

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Shandong Cancer Hospital and Institute

Phase 2 Recruiting
30 enrolled
Gynecologic

Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasms, Endometrial Neoplasms

NCT06942416 2025-04-24

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

Shandong Cancer Hospital and Institute

Phase 2 Recruiting
36 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasm Recurrence, Local, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡